Amalgamated Bank »

Y Mabs Therapeutics shares owned by Amalgamated Bank

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Amalgamated Bank from 13F filings

Historical chart of Amalgamated Bank investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Amalgamated Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Amalgamated Bank

Quarter filed Position value Share count Share price at filing
2024-03-31 $20k 1.2k 16.43
2023-12-31 $28k 4.1k 6.79
2023-09-30 $24k 4.5k 5.35
2023-06-30 $30k 4.5k 6.69
2023-03-31 $25k 5.0k 4.95
2022-12-31 $28k 5.8k 4.81
2022-09-30 $84k 5.8k 14.44
2022-06-30 $87k 5.7k 15.19
2022-03-31 $68k 5.7k 11.92
2021-06-30 $223k 6.6k 33.79
2020-12-31 $236k 4.8k 49.54
2020-06-30 $207k 4.8k 43.20